false
Catalog
What is Different About Opioid Dependent Patients ...
Recording
Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The discussion focuses on opioid use disorders, emphasizing the high smoking rates among those with psychiatric and substance use disorders (PSUD) and how to assist them in quitting smoking. The Substance Abuse and Mental Health Services Administration (SAMHSA) has created the Opioid Response Network (ORN) to provide resources, local consultation, and technical assistance for evidence-based prevention treatment and recovery of opioid and stimulant use disorders. Studies indicate a strong link between smoking and substance use disorders, highlighting nicotine's complex interaction with multiple neurotransmitter systems, making it difficult to quit. This discourse stresses the importance of treating nicotine addiction to prevent relapses in substance use recovery. Despite improvements in tobacco treatment within substance use facilities, comprehensive care, which includes both medications and therapy, remains underused. Nicotine replacement therapies (NRTs) like the patch, gum, and lozenges can help reduce cravings, particularly when used in combination. Furthermore, medications like bupropion and varenicline (Chantix) can enhance quitting success, especially when tailored to individual needs. Addressing nicotine addiction as part of comprehensive substance use disorder treatment can significantly improve long-term recovery outcomes.
Keywords
opioid use disorders
psychiatric disorders
substance use disorders
smoking cessation
Opioid Response Network
nicotine addiction
nicotine replacement therapies
bupropion
varenicline
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English